Malignant rhabdoid tumourmalignant rhabdoid tumour, malignant rhabdoid tumours
Malignant rhabdoid tumour MRT is a very aggressive form of tumour originally described as a variant of Wilms' tumour, which is primarily a kidney tumour that occurs mainly in children
MRT was first described as a variant of Wilms' tumour of the kidney in 19781 MRTs are a rare and highly malignant childhood neoplasm Later rhabdoid tumours outside the kidney were reported in many tissues including the liver, soft tissue, and the central nervous system Several cases of primary intracranial MRT have been reported since its recognition as a separate entity in 1978 The term rhabdoid was used due to its similarity with rhabdomyosarcoma under the light microscope The exact pathogenesis of MRT is unknown
The cerebellum is the most common location for primary intracerebral MRT ie, AT/RT Biggs et al were first to report a primary intracranial MRT around 19872
Although the cell of origin is not known, cytogenetic studies have suggested a common genetic basis for rhabdoid tumours regardless of location with abnormalities in chromosome 22 commonly occurring
- 1 Rhabdoid tumours in kidney and brain
- 11 Diagnosis
- 2 Prognosis
- 3 Genetics
- 4 See also
- 5 References
- 6 Literature
- 7 External links
Rhabdoid tumours in kidney and brainedit
Considerable debate has been focused on whether AT/RTs are the same as rhabdoid tumours of the kidney ie, just extra-renal MRTs malignant rhabdoid tumours The recent recognition that both CNS atypical teratoid/rhabdoid tumours AT/RTs and MRTs have deletions of the INI1 gene in chromosome 22 indicates that rhabdoid tumours of the kidney and brain are identical or closely related entities, although the CNS variant tends to have its mutations on Taxon 9 and MRTs elsewhere This observation is not surprising because rhabdoid tumours at both locations possess similar histologic, clinical, and demographic features Moreover, 10-15% of patients with MRTs have synchronous or metachronous brain tumours, many of which are second primary malignant rhabdoid tumours This similarity excludes composite rhabdoid tumours, which occur mainly in adults
The histologic diagnosis of malignant rhabdoid tumour depends on identification of characteristic rhabdoid cells—large cells with eccentrically located nuclei and abundant, eosinophilic cytoplasm However, the histology can be heterogeneous and the diagnosis of MRT can often be difficult Misclassifications can occur
In MRTs, the INI1 gene SMARCB1on chromosome 22q functions as a classic tumour suppressor gene Inactivation of INI1 can occur via deletion, mutation, or acquired UPD3
In a recent study,3 SNP array karyotyping identified deletions or LOH of 22q in 49/51 rhabdoid tumours Of these, 14 were copy neutral LOH or acquired UPD, which is detectable by SNP array karyotyping, but not by FISH, cytogenetics, or arrayCGH MLPA detected a single exon homozygous deletion in one sample that was below the resolution of the SNP array SNP array karyotyping can be used to distinguish, for example, a medulloblastoma with an isochromosome 17q from a primary rhabdoid tumour with loss of 22q112 When indicated, molecular analysis of INI1 using MLPA and direct sequencing may then be employed Once the tumour-associated changes are found, an analysis of germline DNA from the patient and the parents can be done to rule out an inherited or de novo germline mutation or deletion of INI1, so that appropriate recurrence risk assessments can be made3
Regardless of location, all rhabdoid tumours are highly aggressive, have a poor prognosis, and tend to occur in children less than two years of age
There have been reported cases of a child having both atypical teratoid rhabdoid tumours in the brain as well as rhabdoid tumours of the kidney Weeks and associates reported on 111 renal rhabdoid cases of which 135% also had a central nervous system malignancy It has been hypothesized that a germline INI mutation may predispose a child to these tumours There have been some references in the literature alluding to a new diagnosis called rhabdoid predispostion syndrome related to the gene hSNF5/INI1
- Epithelioid sarcoma
- Atypical teratoid rhabdoid tumour
- ^ Beckwith JB, Palmer NF 1978 "Histopathology and prognosis of Wilms tumors: results from the First National Wilms' Tumor Study" Cancer 41 5: 1937–48 PMID 206343 doi:101002/1097-014219780541:5<1937::AID-CNCR2820410538>30CO;2-U
- ^ PJ Biggs; Garen PD; Powers JM; Garvin AJ 1987 "Malignant rhabdoid tumor of the central nervous system" Hum Pathol 18 4: 332–337 PMID 3030922 doi:101016/S0046-81778780161-2
- ^ a b c Jackson EM, Sievert AJ, Gai X, et al March 2009 "Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors" Clin Cancer Res 15 6: 1923–30 PMC 2668138 PMID 19276269 doi:101158/1078-0432CCR-08-2091
- Donner LR, Wainwright LM, Zhang F, Biegel JA 2007 "Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium" Hum Pathol 38 6: 935–9 PMC 1963314 PMID 17376508 doi:101016/jhumpath200612003
- Jeffrey S Dome, MD; D Ashley Hill, MD January 8, 2007 "Malignant Rhabdoid Tumor" EMedicine from WebMD
- Perry A, Fuller CE, Judkins AR, Dehner LP, Biegel JA 2005 "INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas" Mod Pathol 18 7: 951–8 PMID 15761491 doi:101038/modpathol3800375
- Biegel JA, Fogelgren B, Wainwright LM, Zhou JY, Bevan H, Rorke LB 2000 "Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor" abstract page Genes Chromosomes Cancer 28 1: 31–7 PMID 10738300 doi:101002/SICI1098-226420000528:1<31::AID-GCC4>30CO;2-Y
- Huret J, Sevenet N 2000 "Rhabdoid predispostion syndrome" Atlas of Genetics and Cytogenetics in Oncology and Haematology 1: 31–7 Archived from the original on 2005-12-26
- Weeks DA, Beckwith JB, Mierau GW, Luckey DW 1989 "Rhabdoid tumor of kidney A report of 111 cases from the National Wilms' Tumor Study Pathology Center" Am J Surg Pathol 13 6: 439–58 PMID 2543225 doi:101097/00000478-198906000-00001
- iSTAR AT/RT Initiative for the Study and Translational AT/RT Research
- Malignant rhabdoid tumor — humpathcom
|Not otherwise specified||
|Connective tissue neoplasm||
|Complex mixed and stromal||
malignant rhabdoid tumour, malignant rhabdoid tumours
Malignant rhabdoid tumour Information about
Malignant rhabdoid tumour
Malignant rhabdoid tumour
Malignant rhabdoid tumour viewing the topic.
There are excerpts from wikipedia on this article and video
Our site has a system which serves search engine function.
You can search all data in our system with above button which written "What did you look for? "
Welcome to our simple, stylish and fast search engine system.
We have prepared this method why you can reach most accurate and most up to date knowladge. The search engine that developed for you transmits you to the latest and exact information with its basic and quick system.
You can find nearly everything data which found from internet with this system.